Davidson, Bruce LRefine your research by the most used items
Author / Editor
- Bounameaux, Henri (5)
- Prins, Martin H (5)
- Brighton, Timothy A (4)
- Cohen, Alexander T (4)
- Decousus, Hervé (4)
- Lensing, Anthonie W A (4)
- Wells, Philip S (4)
- Bauersachs, Rupert (3)
- Berkowitz, Scott D (3)
- Beyer-Westendorf, Jan (3)
Document type
Full text accessibility
Full text version
Subject
Highlights
Show items per page
remove all| Title | Authors / Editors | Date | |
|---|---|---|---|
 |
Risk of recurrent venous thromboembolism according to baseline risk factor profiles | Prins, Martin H; Lensing, Anthonie W A; Prandoni, Paolo; Wells, Philip S; ... Weitz, Jeffrey I | 2018 |
|
|
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism | Weitz, Jeffrey I; Lensing, Anthonie W A; Prins, Martin H; Bauersachs, Rupert; ... Prandoni, Paolo | 2017 |
|
|
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension | Wells, Philip S; Prins, Martin H; Levitan, Bennett; Beyer-Westendorf, Jan; ... Lensing, Anthonie W A | 2016 |
|
|
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies | Prins, Martin H; Lensing, Anthonie Wa; Bauersachs, Rupert; van Bellen, Bonno; ... Wells, Philip S | 2013 |
|
|
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism | Büller, Harry R; Prins, Martin H; Lensing, Anthonie W A; Decousus, Hervé; ... Segers, Annelise | 2012 |
